This study evaluated the safety and efficacy of a single administration of a recombinant adenovirus encoding human aquaporin-1 (AdhAQP1) to the parotid glands of adult rhesus monkeys. In anticipation of possible clinical use of this virus to correct irradiation damage to salivary glands, AdhAQP1 was administered (at either 2 ϫ 10 9 or 1 ϫ 10 8 plaque-forming units/gland) intraductally to irradiated glands and to their contralateral nonirradiated glands. Radiation (single dose, 10 Gy) significantly reduced salivary flow in exposed glands. Virus administration resulted in gene transfer to irradiated and nonirradiated glands and was without untoward local (salivary) or systemic (sera chemistry, complete blood count) effects in all animals. However, the effect of AdhAQP1 administration varied and did not result in a consistent positive effect on salivary flow rates for all animals under these experimental conditions. We conclude that a single adenoviral-mediated gene transfer to primate salivary glands is well-tolerated, although its functional utility in enhancing fluid secretion from irradiated parotid glands is inconsistent.
ach year in the United States ϳ30,000 individuals experience a loss of salivary function as a result of radiation damage to salivary glands. 1 Salivary gland epithelial cells exposed to ionizing radiation during the course of therapy for head and neck cancers can be irreversibly damaged. 2, 3 The salt-and water-secreting acinar cells are considered most sensitive to radiation damage. 4 -6 In the absence of acinar cells, salivary fluid secretion is impossible. 7 No satisfactory treatment presently exists for this condition. However, gene transfer in vivo offers a novel way to treat conditions affecting parenchymal tissues, 8 -10 such as the secretory hypofunction that occurs secondary to radiation damage to major salivary glands. 11 Recently, work from our laboratory showed that it was possible to increase salivary fluid flow from irradiation (IR)-damaged submandibular glands in a rat model through an adenoviral-mediated transfer of human aquaporin-1 (hAQP1) cDNA to surviving epithelial cells. 11 In irradiated rats whose submandibular gland salivary flow rate was reduced ϳ65%, AQP1 cDNA transfer led to near normal levels of salivary secretion 3 days after recombinant virus administration. Thus, initial experiments indicated the possible value of gene transfer to manage this clinical problem.
Salivary glands are an uncommon site of gene transfer. They form part of the mucosal immune system, and their response to adenoviral vectors, at least in rats, is multifaceted. 12 Although currently used adenoviral vectors are not considered ideal for long-term stable gene transfer in mammals, they are, at present, the most efficient means for transferring genes to salivary glands in vivo. 13 Despite the clinical promise shown by recombinant adenoviruses for gene transfer to the salivary glands, there are no published reports examining adenovirus administration to salivary or other exocrine glands in primates. The primary purpose of the present study was to examine the safety of a single administration of a recombinant adenovirus to irradiated and nonirradiated parotid glands of rhesus monkeys. A secondary purpose was to determine whether the transfer of AQP1 cDNA under the experimental conditions could increase salivary fluid flow from the irradiated primate glands.
MATERIALS AND METHODS

Animals
Five adult male rhesus monkeys (Macaca mulatta) were used in this study (weight: 7.7-9.8 kg). The animals were housed individually and fed commercial rations supplemented with fresh fruit. Water was available ad libitum. The animals were immobilized for all procedures using an intramuscular (i.m.) injection of ketamine (10 -30 mg/kg) and xylazine (0.5-1.5 mg/kg). The sequence of the experimental procedures is depicted in Figure 1 .
Radiation
Radiation was delivered to the right parotid gland via a Clinac 20 linear accelerator (Varian, Palo Alto, Calif) using 12 million electronvolts dosed to 95%. The dose rate was 300 cGy/min at a source to skin distance of 100 cm. Electron beam IR was used in an attempt to minimize the radiation exposure to the contralateral parotid gland. The animals were shaved and placed in lateral recumbency, and a single treatment of 10 Gy was delivered unilaterally. The radiation field was defined using the following anatomical landmarks:
14 the anterior and posterior borders were the canine tooth and the transverse process of the first cervical vertebrae, respectively. The superior border was defined by the zygoma, whereas the lower border of the mandible was the inferior border. These boundaries maximized the inclusion of the right parotid gland while also minimizing the involvement of the submandibular/sublingual glands.
Saliva collection
All collections were done within a specified time of day (usually 11 a.m. to 12 p.m.) and at the timepoint indicated by the experimental time line (Fig 1) . The animals were placed in a semireclined position. Specially constructed miniature Carlson-Crittenden cups were placed over the orifice of the parotid ducts bilaterally. 15 The orifice was located on the buccal mucosa adjacent to the first molar and was visualized directly. Pilocarpine was used to elicit salivary flow (0.75-2 mg/animal; i.m. injection), with the dose used being consistent within each animal. The first drop of saliva was discarded, and the collection was timed for a total of 10 minutes. Salivary volumes were determined gravimetrically, and flow rates are expressed as milliliters per minute per gland. Atropine (0.5 mg/animal; i.m. injection) was administered following salivary collection to limit further secretions.
Laboratory analysis
Blood was drawn at the indicated timepoints and analyzed by sera chemistry. Complete blood counts with differential and erythrocyte sedimentation rates (ESR) were also determined.
Virus preparation and delivery
All monkeys were subjected to in vivo adenoviral-mediated gene transfer to both the irradiated and nonirradiated parotid glands at 19 weeks post-IR. AdhAQP1 is a replication-deficient recombinant virus encoding hAQP1 that includes the cytomegalovirus promoter/enhancer and a simian virus 40 polyadenylation signal. 11 A functionally irrelevant virus for these experiments, AdCMVH3 (encoding the human salivary protein histatin 3), was used as control virus. 16 Recombinant adenoviruses were plaque-purified and isolated by equilibrium centrifugation on a CsCl gradient as reported previously. 17 Using these methods, we have been able to show that there are Ͻ1 in 10,000 E1A-positive particles in our vector preparation. 17 All experiments performed herein used a single batch of AdhAQP1 with a particle to plaque-forming unit (PFU) ratio of 273:1 and a final titer of 3.4 ϫ 10 10 PFU/mL. Virus was stored in dilution buffer (10 mM tris(hydroxymethyl)aminomethane (pH 7.4), 1 mM MgCl 2 , and 10% glycerol) at Ϫ80°C until use. At 1 day prior to delivery of the virus, all animals were given a single i.m. dose of the corticosteroid methylprednisolone (Depo-Medrol, 20 mg/animal); saliva was collected as described previously. Atropine (0.5-1.0 mg/animal) was administered by i.m. injection ϳ5 minutes before virus delivery. Virus was resuspended in 500 L of dilution buffer and delivered to parotid glands by retrograde intraductal instillation. Two monkeys received 2 ϫ 10 9 PFU AdhAQP1 (high dose), two monkeys received 1 ϫ 10 8 PFU AdhAQP1 (low dose), and one monkey received 2 ϫ 10 9 PFU AdCMVH3 (control virus).
Histological/immunocytochemical evaluation
Biopsies of parotid glands were obtained at 3 days after virus administration using a standard surgical approach to the superficial lobe, based on anatomical location. 14 The tissue was fixed by immersion in 10% formalin. Tissue was trimmed and embedded in paraffin, and sections were cut at a thickness of 3-4 m. Samples were subsequently deparaffinized in xylene, rehydrated with a graded series of ethanol/water washes, and either stained with hematoxylin and eosin or processed for immunochemical detection of the transgene. Immunohistochemistry was performed using an affinity-purified antibody to Figure 1 . Time line of experimental procedures. IR, 10 Gy IR; V, virus administration. "Saliva" and "Blood" indicate the days on which these samples were obtained. "Biopsy" indicates the day on which the biopsy of the parotid gland was performed (except for animal A, for which the biopsy was performed on day 7 due to an inadvertent administration of atropine). "Steroid" indicates the day on which animals received a single i.m. administration of Depo-Medrol.
hAQP1 at a 1/50 dilution 18 and using the Histostain SP kit (Zymed, San Francisco, Calif).
Statistical analysis
Data were analyzed using paired Student's t tests with each animal as its own control.
RESULTS
Effect of IR on primate parotid flow rates
Prior to IR (10 Gy), the range of pilocarpine-stimulated salivary flow rates in the five primates was 0.56 -1.3 mL/min/parotid gland. There was no significant difference between the flow rates on either the right (0.93 Ϯ 0.27 mL/min) or the left (0.93 Ϯ 0.31 mL/min) sides in any animal. At 1 week post-IR, parotid salivary flow rates on the irradiated side had decreased 40 -100% (P Ͻ .003; Fig 2) . Conversely, flow rates from the contralateral gland at this timepoint were essentially unchanged or slightly increased (119 Ϯ 28%). At 19 weeks post-IR, all animals still showed profound reductions in parotid flow from their irradiated gland (ϳ50 -90%; Fig 2) . Interestingly, all contralateral nonirradiated glands at this timepoint exhibited some reduction in parotid flow rates from pre-IR levels (ϳ10 -55%; Fig 2) . However, lower flow rates were seen from the irradiated gland (0.27 Ϯ 0.17 mL/min) compared with the nonirradiated side (0.59 Ϯ 0.23 mL/min; P Ͻ .003) in all animals.
Effect of virus administration on animals
At 19 weeks post-IR, each animal received a bolus of recombinant adenovirus to both the irradiated right and nonirradiated left parotid gland. A high dose of AdhAQP1 (2 ϫ 10 9 PFU/gland) was administered to two animals, whereas two other animals received the same virus but at a lower dose (1 ϫ 10 8 PFU/gland). The remaining monkey received a high dose (2 ϫ 10 9 PFU/ gland) of a control virus, AdCMVH3. All animals tolerated virus administration well. No animals became febrile, and there was no noticeable change in food consumption. When saliva was collected from animals 3 days after virus was administered, no clinical abnormalities in appearance or consistency were noted in any sample.
Samples of blood were obtained at each study timepoint after virus administration (Fig 1) . There was no significant change in general sera chemistry parameters (electrolytes, specific and total protein, or liver function) following virus administration for any of the animals. Hematological examination before and after virus administration for all animals revealed all values to be within the normal range. However, the percentage of lymphocytes was decreased following virus administration in each animal. This likely represents a secondary effect, reflecting an increase in the polymorphonuclear cells associated with the transient acute inflammatory response to the administration of recombinant adenovirus, as reported previously. 17 Effect of AdhAQP1 on parotid salivary flow rates The response to salivary gland administration of AdhAQP1 was variable (Fig 3) , although generally similar in both the right and left glands. The results are depicted as the percent change from the previral timepoint (PRE-V, which is the same as the 19 weeks post-IR timepoint, IRϩ19 week, in Fig 2) . The two animals receiving the high dose of AdhAQP1 (Fig 3, A and B) essentially showed no overall change in salivary flow rates from either parotid gland. Both animals receiving the lower dose of AdhAQP1 showed an elevation in salivary flow rates, although of considerably different magnitudes. One animal (Fig 3C) showed a sustained increase of Ն2-fold in both glands after AdhAQP1 treatment; the increase in flow was more modest in the other animal (ϳ20 -50%), but also was sustained over the 14 days. The animal that received the control virus, AdCMVH3 (Fig 3E) , which should have no effect on transcellular fluid movement, showed an inconsistent pattern: ϳ65% increase by day 3, return to baseline at day 7, and a 25-50% increase at day 14. The most significant increase was noted in animal C (Fig 3C) , in which the administration of AdhAQP1 increased the output of the irradiated salivary gland from 0.06 mL/ min/gland to 0.16 mL/min/gland. However, this increase represents only a 14.3% recovery of the initial pre-IR flow rate of this animal (0.7 mL/min/gland).
Histological appearance of salivary glands after virus administration A biopsy was obtained from the superficial lobe of the irradiated right parotid gland in each animal at 3 days after virus administration. In addition, a similar biopsy was performed on the nonirradiated, left parotid gland in two animals. As expected, both nonirradiated gland biopsies revealed the presence of essentially normal gland tissue upon histological examination (Fig 4A) . Conversely, all irradiated gland biopsies showed variable inflammatory cell infiltration, predominantly of mononuclear cells with scattered neutrophils (Fig 4B) . Parenchymal cells adjacent to the inflammatory infiltration demonstrated atrophic changes. A loss of acinar cells was noted in some areas, as well as in regions of fibrosis. A number of ducts were found to be dilated, containing cellular debris and inspissated secretions. Blood vessels showed congestion, with a few areas of thrombosis.
Expression of hAQP1 in salivary parenchymal cells
In general, the transgene expression in monkey salivary glands was lower than that seen in rat submandibular glands following the administration of the same dose of virus.
10,11 Figure 5A demonstrates positive immunostaining for AQP1, primarily in capillaries and venules in control gland tissue (AdCMVH3; animal E). In animals receiving AdhAQP1, positive staining was seen in some acinar and ductal elements in addition to the vascular immunoreactivity. The immunostaining was most evident on the apical and lateral surfaces of acinar cell plasma membranes (Fig 5B) . The present results were consistently observed during repeated immunohistochemical evaluations with this transgene product. No differences were noted in the localization of hAQP1 between the irradiated and nonirradiated glands in these animals.
DISCUSSION
Radiation injury to the major salivary glands following therapy for head and neck cancer causes significant oral disease. A loss of salivary function is distressing and leads to significant morbid consequences such as dysphagia, rampant caries, pain, and mucositis. 19, 20 Non-human primate salivary glands are similar morphologically and physiologically to those of humans and also closely mimic the effects of radiation damage in humans. [2] [3] [4] 6 The parotid gland is generally considered to be much more sensitive to radiation damage than the submandibular gland, and hence was the focus of our studies. 8 PFU AdhAQP1; E: 2 ϫ 10 9 PFU AdCMVH3. Only the right (R) parotid gland was irradiated (single dose, 10 Gy). Data represent the percent change in flow rate, where salivary flow prior to virus administration (PRE-V; same value as the IRϩ19 weeks timepoint in Fig 2) is considered as 100%. Salivary flow rates were also obtained at 3, 7, and 14 days after virus administration.
Previous studies from our laboratory have shown that gene transfer to salivary glands in a rat model can be readily accomplished using recombinant adenoviral vectors. 10, 16 Those studies have suggested several potentially useful clinical applications of this maneuver. Preclinical studies examining adenoviral-mediated gene transfer to the salivary glands of non-human primates should provide valuable information for eventual, planned human studies, based on the results of several studies using recombinant adenoviruses encoding the cystic fibrosis transmembrane conductance regulator.
21-23
Herein, we have presented the first report of viralmediated gene transfer to primate salivary glands. Our most important finding was that a single adenoviralmediated gene transfer to macaque salivary glands was without untoward effects. The macaque parotid gland, like its human homolog, is well-encapsulated, a circumstance that likely limits any regional or general systemic availability of the administered virus. In the rat model, in which the parotid gland is nonencapsulated, little or no transgene expression was seen in other tissues following delivery into the salivary glands. 24 For this reason, an analysis of blood, urine, and feces for the presence of adenovirus was not performed, although we cannot exclude the possibility that some virus may have disseminated beyond the salivary glands. Importantly, none of the animals studied by us showed any local or systemic clinical signs indicating an adverse reaction to the viral vector. Further, clinical laboratory studies showed no consistent general pattern that was indicative of any significant pathological effects resulting from intraductal transduction of salivary glands with the recombinant adenovirus.
Several studies have examined adenoviral-mediated gene transfer to non-human primate lungs in anticipation of clinical studies with cystic fibrosis patients. In these studies, animals that were similar in size were administered much larger doses of recombinant virus (10 9 -Ͼ10 10 PFU). [21] [22] [23] Our results with salivary glands are in keeping with previous studies in which the absence of any significant adverse effect of adenoviral transduction was a common finding.
A second important aspect of this study addressed the efficacy of AdhAQP1 in (a) mediating gene transfer to Sections of glands were obtained as described in the legend to Figure 4 and stained with the affinity-purified antibody against hAQP1 as described in the text. A: Section from animal E, which received the control virus AdCMVH3 (2 ϫ 10 9 PFU). Arrows show the immunostaining of endogenous primate AQP1 in the endothelial cells of capillaries and venules. B: Section from animal A, which received the experimental virus AdhAQP1 (2 ϫ 10 9 PFU). Arrows point to the hAQP1-positive immunostaining in the primarily apical and lateral plasma membranes of acinar and ductal parenchymal cells. Sections were counterstained with hematoxylin; magnification is ϫ400.
primate salivary glands and (b) enhancing fluid secretion from IR-damaged salivary glands. Although the overall level of gene transfer achieved appeared low as judged by immunohistochemical results, the present study has shown that adenoviral-mediated gene transfer is possible in a dysfunctional primate salivary gland. We believe that the low level of transduction could be due to several factors. First, the viral dose chosen might be less than optimal for the effective transduction of primate salivary gland cells. Second, the relative dose of virus used per milligram of gland tissue, was roughly 8-fold less than that administered previously to rats, due to the fact that a macaque salivary gland is substantially larger than a rat salivary gland. 25 In addition, the relative volume of the infusate used herein (500 L) was less than the volume used in rats (50 L), if one accounts for gland volume. The selection of the 500-L volume was based on a sialographic assessment of the primate parotid gland, which gave an optimum "clinical" fill of the gland with good resulting radiographic morphology. However, in recent studies using mice (S. Wang et al, unpublished observations), optimal gene transfer occurred when the infusate volume distended but did not damage the submandibular gland, suggesting that infusate volume is an important variable affecting maximal gene transfer. For the present study, gland distention by the infusate would have required three times the volume actually employed (our unpublished observations). Thus, it is possible that the recombinant virus was not adequately delivered to the most distal cells in the macaque gland. Third, the efficiency of transduction may be influenced by the differences between primate and rodent salivary glands. Our rodent studies delivered recombinant adenovirus to the submandibular glands, and the whole gland was available for histological evaluation. Parotid glands in non-human primates are structurally different from the submandibular glands and contain morphologically different cell types; only the most distal, superficial portion of the gland was biopsied. In addition, we have shown previously that the luminal membranes of the primate parotid epithelial cells express a different distribution of integrin subunits than that found on rodent salivary gland cells. 26 These integrin subunits are necessary for internalization of the virus.
The conclusion that the virus was not adequately delivered to the most distal cells of the parotid gland is further supported by the uneven immunohistochemical detection of hAQP1 in the parenchymal cells (see below). We measured gene transfer efficacy by an immunohistochemical method, which requires a biopsy. AQP1 is an integral membrane protein and cannot be detected as conveniently as, for example, a circulating protein. An important consideration for the present study was to maintain the general health of the animal, ensuring survival. Thus, the biopsy sample was obtained only from the superficial lobe of the parotid gland. Given that it is most likely that the recombinant virus was inadequately perfused into the gland (see above), the superficial lobe as the most distal gland portion probably was exposed to a low virus bolus. Thus, we interpret the immunohistochemical results as representing a minimal estimate for gene transfer efficacy. Overall, our present results indicate that additional studies are required to define the optimal conditions for maximal gene transfer to parotid glands in primates using adenoviral vectors.
As noted above, AQP1 is only found in the endothelial cells of capillaries and venules in normal primate parotid glands (Fig 5) . The immunohistochemical localization of AQP1 in transduced glands includes significant numbers of epithelial cells. However, the membrane distribution of AQP1 in these epithelial cells is somewhat unusual. AQP1, as the archetypal water channel, is the most well-studied member of the aquaporin family. In rodent and human cells that express AQP1, it displays a nonpolarized location (apical and basolateral membranes). 18, 27 However, it has been reported recently that in the developing human proximal tubule, 27 AQP1 primarily has an apical membrane localization. We are unaware of any published reports on AQP1 distribution in non-human primate epithelial cells.
Our previous studies in irradiated rats showed that AdhAQP1 was effective in enhancing fluid secretion from submandibular glands. 11 In the present study, AdhAQP1 did not consistently increase fluid secretion from irradiated primate parotid glands. All irradiated glands showed reductions in flow prior to virus administration. In addition, all contralateral nonirradiated glands showed reductions in flow prior to virus administration, despite our efforts to limit this effect by controlling the field and the depth of beam penetration. High doses of AdhAQP1 (2 ϫ 10 9 PFU/gland) were essentially without effect on salivary gland function. In the two animals receiving lower doses (10 8 PFU/gland) of AdhAQP1, however, increases in salivary flow were sustained over the 14-day observation period. Animal C showed a Ͼ2-fold increase in flow over previrus levels in both the right and left sides, whereas the increase in animal D was ϳ30% above previrus administration levels. However, these increases in salivary flow were minimal relative to the salivary output of the animal prior to IR. Finally, one animal received a high dose (2 ϫ 10 9 PFU/gland) of the control virus AdCMVH3. In this animal, salivary flow rates in both glands showed considerable variability, ranging from 100% to 170% of previrus values over the 14-day study period.
These aggregate results may well represent a true picture of AdhAQP1 efficacy (i.e., some degree of improvement is afforded in some animals). Interestingly, the effect of IR on gland function was similar for animals A, C, and D (Fig 2) (i.e., marked reduction on the ipsilateral side and a modest decrease on the contralateral side). The remaining two animals showed a slightly different pattern of IR effects. In a patient population, variability in IR damage is also quite common. 2,3,28 -30 Thus, the utility of AdhAQP1 to increase fluid flow from irradiated glands may well be influenced by the baseline tissue damage, by the viral dose administered, and by the volume of infusate used. The present study examined only a small number of experimental animals versus those available for study in our previous rodent experi-ments. Studies with additional primates are required to help clarify the questions raised herein. In addition, it is important to consider that adenoviral vectors may not be optimal for the purposes tested by us. As noted above, recombinant adenoviruses elicit a potent immune response in rodent salivary glands. 12, 17 Alternative vectors are being developed that should permit stable transgene expression in these glands. Recently, we have shown that gene transfer to mouse salivary glands can be mediated by a recombinant type 2 adeno-associated virus (rAAV).
31 rAAVs are less immunogenic than adenoviruses, and advances in rAAV production methods may lead to high-titer, adenoviral-free preparations.
32 Also, hybrid vectors that combine the desirable features of two viruses have shown increased utility in several tissues. 33 In summary, the present report has shown that there are no overt, adverse effects of a single administration of a recombinant type 5 adenovirus to parotid glands of non-human primates. Using AdhAQP1, the transfer and expression of hAQP1 cDNA was observed in macaque salivary epithelial cells. Finally, additional studies are needed to optimize the conditions for maximal adenoviral gene transfer to primate salivary glands to rigorously test their potential utility for the correction of salivary hypofunction in irradiated human patients. 
